View SPAC Presentation Deck

Consolidated Statements of Comprehensive Loss (in thousands) 42 Revenue Costs and expenses: Cost of sales (1) Research and development (2) Selling, general an administrative (3) (Gain) loss from legal settlement Total costs and expenses Loss from operations Other expenses, net: Interest and other income Interest and other expense Change in fair value of redeemable convertible preferred stock warrant liability Loss on extinguishment of debt Other expense, net Loss before provision of income taxes Provision for income taxes Net loss Other comprehensive loss Comprehensive loss YTD - Sept 30, 2020 $24,539 91,825 50,344 62,835 205,004 (180,465) 536 (19,442) (2,296) (21,202) (201,667) (31) (201,698) $(201,698) Year Ended December 31 (2) Research and development stock-based compensation was $3,971 in the nine months ending September 30, 2020 and $4,113 and $671 in 2019 and 2018, respectively (3) Selling, general and administrative stock-based compensation was $16,953 in the nine months ending September 30, 2020 and $21,879 and $4,934 in 2019 and 2018, respectively 2019 $24,324 179,674 77,696 72,904 (22,500) 307,775 (283,451) 5,593 (10,705) 1,749 (3,040) (6,402) (289,853) (51) (289,904) $(289,904) 2018 $20,175 142,646 33,655 81,219 20,708 278,228 (258,053) 167 (31,914) (80,338) (71,362) (183,447) (441,500) (441,500) $(441,500) The financial statement information and data of View contained herein have been derived from the financial statements of View that are currently subject to audit in accordance with the rules of the Public Company Accounting Oversight Board ("PCAOB") and may be updated or modified in the final audited financial statements in the proxy statement with respect to the meeting of CFII's stockholders relating to CFII's business combination with View and the related registration statement on Form S-4. Accordingly, such information and data may not be included in or may be presented differently in any proxy statement/prospectus or registration statement to be filed by CFII with the SEC. (1) Cost of sales stock-based compensation was $1,654 in the nine months ending September 30, 2020 and $3,084 and $578 in 2019 and 2018, respectively view

View entire presentation